Table 3.

PCSM Unadjusted Univariate and Adjusted Multivariate Fine and Gray Analysis

	Univariate		Multivariate
	P-Value	HR (95% CI)	P-Value	HR (95% CI)
Age >65 vs ≤65	0.21	0.65 (0.34–1.26)	–	–
T-stage	<0.001	1.40 (1.2–1.64)	0.033	1.22 (1.02–1.45)
Gleason score	<0.001	1.98 (1.58–2.49)	0.004	1.51 (1.14–2.01)
PSA	0.4	1.01 (0.98–1.01)	–	–
ADT (yes vs no)	0.021	2.83 (1.17–6.83)	–	–
% Core Positivity (>50% vs ≤50%)	<0.001	4.87 (2.41–9.85)	0.003	3.15 (1.49–6.67)
PSA density (>0.25 vs ≤0.25)	0.017	2.25 (1.15–4.37)	–	–

Abbreviations: ADT, androgen-deprivation therapy; CI, confidence interval; HR, hazard ration; PSA, prostate-specific antigen